166 related articles for article (PubMed ID: 23798324)
1. Liver transplantation with a strongly positive crossmatch: case study and literature review.
Leonard GR; Shike H; Uemura T; Gaspari JL; Ruggiero FM; Shah RA; Riley TR; Kadry Z
Liver Transpl; 2013 Sep; 19(9):1001-10. PubMed ID: 23798324
[TBL] [Abstract][Full Text] [Related]
2. Pretransplant donor-specific anti-HLA antibodies as predictors of early allograft rejection in ABO-compatible liver transplantation.
Musat AI; Pigott CM; Ellis TM; Agni RM; Leverson GE; Powell AJ; Richards KR; D'Alessandro AM; Lucey MR
Liver Transpl; 2013 Oct; 19(10):1132-41. PubMed ID: 23873778
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter?
Crespo M; Torio A; Mas V; Redondo D; Pérez-Sáez MJ; Mir M; Faura A; Guerra R; Montes-Ares O; Checa MD; Pascual J
Transpl Immunol; 2013 Dec; 29(1-4):28-33. PubMed ID: 23907088
[TBL] [Abstract][Full Text] [Related]
4. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
[TBL] [Abstract][Full Text] [Related]
5. Preformed C1q-binding Donor-specific Anti-HLA Antibodies and Graft Function After Kidney Transplantation.
Okabe Y; Noguchi H; Miyamoto K; Kaku K; Tsuchimoto A; Masutani K; Nakamura M
Transplant Proc; 2018 Dec; 50(10):3460-3466. PubMed ID: 30577221
[TBL] [Abstract][Full Text] [Related]
6. Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation.
O'Leary JG; Kaneku H; Jennings LW; Bañuelos N; Susskind BM; Terasaki PI; Klintmalm GB
Liver Transpl; 2013 Sep; 19(9):973-80. PubMed ID: 23780820
[TBL] [Abstract][Full Text] [Related]
7. The complement interference phenomenon as a cause for sharp fluctuations of serum anti-HLA antibody strength in kidney transplant patients.
Guidicelli G; Anies G; Bachelet T; Dubois V; Moreau JF; Merville P; Couzi L; Taupin JL
Transpl Immunol; 2013 Dec; 29(1-4):17-21. PubMed ID: 24056164
[TBL] [Abstract][Full Text] [Related]
8. Post-transplant development of C1q-positive HLA antibodies and kidney graft survival.
Piazza A; Poggi E; Ozzella G; Adorno D
Clin Transpl; 2013; ():367-75. PubMed ID: 25095531
[TBL] [Abstract][Full Text] [Related]
9. C1q assay for the detection of complement fixing antibody to HLA antigens.
Chen G; Tyan DB
Methods Mol Biol; 2013; 1034():305-11. PubMed ID: 23775744
[TBL] [Abstract][Full Text] [Related]
10. Antibody-mediated rejection in ABO compatible husband to wife living donor liver transplant and review of the literature.
Kheradmand T; Anthony TL; Harland RC; Testa G; Hart J; Renz J; Te HS; Marino SR
Hum Immunol; 2014 Jun; 75(6):578-83. PubMed ID: 24530823
[TBL] [Abstract][Full Text] [Related]
11. Poor kidney allograft survival associated with positive B cell - Only flow cytometry cross matches: a ten year single center study.
Norin AJ; Mondragon-Escorpizo MO; Brar A; Hochman D; Sumrani N; Distant DA; Salifu MO
Hum Immunol; 2013 Oct; 74(10):1304-12. PubMed ID: 23811689
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of Luminex-based donor-specific antibody mean fluorescence intensity values with complement-dependent cytotoxicity & flow crossmatch results in live donor renal transplantation.
Baranwal AK; Bhat DK; Goswami S; Agarwal SK; Kaur G; Kaur J; Mehra N
Indian J Med Res; 2017 Feb; 145(2):222-228. PubMed ID: 28639599
[TBL] [Abstract][Full Text] [Related]
13. Crossmatch-positive liver transplantation in patients receiving thymoglobulin-rituximab induction.
Kubal CA; Mangus RS; Saxena R; Lobashevsky A; Higgins N; Agarwal A; Fridell JA; Tector AJ
Transplantation; 2014 Jan; 97(1):56-63. PubMed ID: 24030603
[TBL] [Abstract][Full Text] [Related]
14. Importance of human leukocyte antigen antibodies and leukocyte antigen/killer-cell immunoglobulin-like receptor genes in liver transplantation.
Muro M; Legaz I
World J Gastroenterol; 2023 Feb; 29(5):766-772. PubMed ID: 36816626
[TBL] [Abstract][Full Text] [Related]
15. Impact of C1q fixing donor-specific antibodies on renal transplant outcome.
Baranwal AK; Goswami S; Agarwal SK; Kaur G; Mehra NK
Scand J Immunol; 2021 Jul; 94(1):e13048. PubMed ID: 33914934
[TBL] [Abstract][Full Text] [Related]
16. Causes of Positive Pretransplant Crossmatches in the Absence of Donor-Specific Anti-Human Leukocyte Antigen Antibodies: A Single-Center Experience.
Kang H; Yoo J; Lee SY; Oh EJ
Ann Lab Med; 2021 Jul; 41(4):429-435. PubMed ID: 33536364
[TBL] [Abstract][Full Text] [Related]
17. Significance of C1q-fixing donor-specific antibodies after kidney transplantation.
Thammanichanond D; Mongkolsuk T; Rattanasiri S; Kantachuvesiri S; Worawichawong S; Jirasiritham S; Kitpoka P
Transplant Proc; 2014; 46(2):368-71. PubMed ID: 24655965
[TBL] [Abstract][Full Text] [Related]
18. Optimizing transplantation of sensitized heart candidates using 4 antibody detection assays to prioritize the assignment of unacceptable antigens.
Reinsmoen NL; Patel J; Mirocha J; Lai CH; Naim M; Ong G; Wang Q; Zhang X; Liou F; Yu Z; Kobashigawa J
J Heart Lung Transplant; 2016 Feb; 35(2):165-72. PubMed ID: 26683810
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and predictive value for graft fibrosis of the complement-binding capacity of donor-specific human leukocyte antigen antibodies after pediatric liver transplantation.
Tokodai K; Miyagi S; Nakanishi W; Nishimura R; Fujio A; Goto M; Unno M; Kamei T
Pediatr Transplant; 2020 Feb; 24(1):e13648. PubMed ID: 31885148
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of complement-dependent lymphocytotoxicity crossmatch and flow cytometry crossmatch results versus Luminex single-antigen bead-based donor-specific IgG class I antibody MFI values in live related renal transplant cases; a retrospective observation in 102 cases.
Pandey P; Pande A; Kumar Devra A; Kumar Sinha V; Prasad Bhatt A
J Immunoassay Immunochem; 2021 May; 42(3):300-313. PubMed ID: 33356865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]